Daesung Microbiological Labs. Co. Ltd (036480) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.018x

Based on the latest financial reports, Daesung Microbiological Labs. Co. Ltd (036480) has a cash flow conversion efficiency ratio of -0.018x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-624.01 Million ≈ $-422.88K USD) by net assets (₩35.22 Billion ≈ $23.87 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Daesung Microbiological Labs. Co. Ltd - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how Daesung Microbiological Labs. Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Daesung Microbiological Labs. Co. Ltd (036480) total liabilities for a breakdown of total debt and financial obligations.

Daesung Microbiological Labs. Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Daesung Microbiological Labs. Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Mesiniaga Bhd KLSE:5011	0.048x
Bharat Road Network Limited NSE:BRNL	-0.109x
Hubei Geoway Investment Co Ltd SHG:600462	0.893x
Pasithea Therapeutics Corp NASDAQ:KTTA	-0.237x
DATRIX S.P.A. F:BW6	N/A
Aelis Farma SA PA:AELIS	-0.635x
Evoke Pharma Inc NASDAQ:EVOK	-0.155x
4Sight Holdings Ltd JSE:4SI	0.083x

Annual Cash Flow Conversion Efficiency for Daesung Microbiological Labs. Co. Ltd (2012–2024)

The table below shows the annual cash flow conversion efficiency of Daesung Microbiological Labs. Co. Ltd from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Daesung Microbiological Labs. Co. Ltd worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩35.15 Billion ≈ $23.82 Million	₩2.10 Billion ≈ $1.43 Million	0.060x	+281.12%
2023-12-31	₩37.35 Billion ≈ $25.31 Million	₩-1.23 Billion ≈ $-836.14K	-0.033x	-211.04%
2022-12-31	₩38.84 Billion ≈ $26.32 Million	₩1.16 Billion ≈ $783.00K	0.030x	-50.04%
2021-12-31	₩37.00 Billion ≈ $25.08 Million	₩2.20 Billion ≈ $1.49 Million	0.060x	-33.19%
2020-12-31	₩36.31 Billion ≈ $24.61 Million	₩3.24 Billion ≈ $2.19 Million	0.089x	+35.07%
2019-12-31	₩35.09 Billion ≈ $23.78 Million	₩2.32 Billion ≈ $1.57 Million	0.066x	-30.56%
2018-12-31	₩33.01 Billion ≈ $22.37 Million	₩3.14 Billion ≈ $2.13 Million	0.095x	+71.29%
2017-12-31	₩30.30 Billion ≈ $20.53 Million	₩1.68 Billion ≈ $1.14 Million	0.055x	-54.29%
2016-12-31	₩29.01 Billion ≈ $19.66 Million	₩3.52 Billion ≈ $2.39 Million	0.121x	-60.26%
2015-12-31	₩25.09 Billion ≈ $17.01 Million	₩7.66 Billion ≈ $5.19 Million	0.305x	+68.35%
2014-12-31	₩21.14 Billion ≈ $14.32 Million	₩3.83 Billion ≈ $2.60 Million	0.181x	+89.22%
2013-12-31	₩19.72 Billion ≈ $13.36 Million	₩1.89 Billion ≈ $1.28 Million	0.096x	-18.93%
2012-12-31	₩19.73 Billion ≈ $13.37 Million	₩2.33 Billion ≈ $1.58 Million	0.118x	--

About Daesung Microbiological Labs. Co. Ltd

KQ:036480 Korea Biotechnology

Market Cap

$18.95 Million

₩27.97 Billion KRW

Market Cap Rank

#25194 Global

#1877 in Korea

Share Price

₩7360.00

Change (1 day)

-1.74%

52-Week Range

₩6170.00 - ₩9880.00

All Time High

₩27216.09